Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-01-10 Smith Bryan E. General Counsel, Corporate Sec Grant or award · Stock Option (right to buy) +150,500 150,500
2025-01-10 Smith Bryan E. General Counsel, Corporate Sec Grant or award · Restricted Stock Units +64,500 64,500
2024-11-21 Smith Bryan E. General Counsel, Corporate Sec Grant or award · Stock Option (right to buy) +474,350 474,350
2024-06-13 Smith Bryan E. General Counsel, Corporate Sec Grant or award · Stock Option (right to buy) +241,650 241,650
2023-05-01 Smith Bryan E. General Counsel, Corporate Sec Grant or award · Stock Option (right to buy) +179,000 179,000
2023-02-01 Smith Bryan E. General Counsel, Corporate Sec Grant or award · Stock Option (right to buy) +155,000 155,000
2022-02-01 Smith Bryan E. General Counsel, Corporate Sec Grant or award · Stock Option (right to buy) +120,000 120,000
2021-05-03 Smith Bryan E. See Remarks Grant or award · Stock Option (Right to Buy) +158,500 158,500

Page 1 of 1 · 8 trades